Clinical Trials Directory

Trials / Completed

CompletedNCT02010983

Achalasia and Dysplasia

Screening for Dysplasia in Longstanding Idiopathic Achalasia: a Prospective Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
KU Leuven · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patient with achalasia have a 10-50 fold increased risk to develop esophageal squamous cell carcinoma (ESCC). Early diagnosis of ESCC is essential, and detection of an earlier dysplastic stage is preferred. Endoscopic detection is however difficult and often delayed. Chromoendoscopy with Lugol dye increases detection rates dysplasia and ESCC to 91-100%. The aim of this study was therefore to evaluate a screening program using chromoendoscopy with Lugol to detect dysplasia in patients with idiopathic achalasia. A second objective is to study the relationship between foodstasis and the development op dysplasia

Conditions

Interventions

TypeNameDescription
OTHERchromoendoscopychromoendoscopy (lugol stain and virtual chromoendoscopy)

Timeline

Start date
2013-10-01
Primary completion
2016-12-19
Completion
2016-12-19
First posted
2013-12-13
Last updated
2026-03-20

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02010983. Inclusion in this directory is not an endorsement.

Achalasia and Dysplasia (NCT02010983) · Clinical Trials Directory